Functional and Metabolic Magnetic Resonance Imaging and Positron Emission Tomography for Tumor Volume Definition in High-Grade Gliomas

Christina I. Tsien; Yue Cao; Theodore S. Lawrence

doi:10.1016/j.semradonc.2009.02.002

Functional and Metabolic Magnetic Resonance Imaging and Positron Emission Tomography for Tumor Volume Definition in High-Grade Gliomas

Christina I. Tsien, Yue Cao, Theodore S. Lawrence

Research output: Contribution to journal › Review article › peer-review

10 Scopus citations

Abstract

Although the addition of concurrent and adjuvant temozolomide (TMZ) to standard-dose radiation (60 Gy) improves survival, the pattern of failure continues to be local. Conventional contrast enhanced T1-weighted and T2-weighted magnetic resonance imaging (MRI) used for radiation planning reflect anatomic rather than molecular or functional, properties of the tumor. Functional and metabolic MRI and positron emission tomography are able to detect metabolic and functional abnormalities beyond the tumor volume seen on conventional MRI, assess early response to treatment, and delineate the regions of high risks for failure in high-grade gliomas. This article focuses on the potential of these functional and metabolic imaging techniques to refine our clinical target volumes.

Original language	English
Pages (from-to)	155-162
Number of pages	8
Journal	Seminars in Radiation Oncology
Volume	19
Issue number	3
DOIs	https://doi.org/10.1016/j.semradonc.2009.02.002
State	Published - Jul 2009

Access to Document

10.1016/j.semradonc.2009.02.002

Cite this

@article{12b9c3a2e81348cdbf8be032a01cada6,

title = "Functional and Metabolic Magnetic Resonance Imaging and Positron Emission Tomography for Tumor Volume Definition in High-Grade Gliomas",

abstract = "Although the addition of concurrent and adjuvant temozolomide (TMZ) to standard-dose radiation (60 Gy) improves survival, the pattern of failure continues to be local. Conventional contrast enhanced T1-weighted and T2-weighted magnetic resonance imaging (MRI) used for radiation planning reflect anatomic rather than molecular or functional, properties of the tumor. Functional and metabolic MRI and positron emission tomography are able to detect metabolic and functional abnormalities beyond the tumor volume seen on conventional MRI, assess early response to treatment, and delineate the regions of high risks for failure in high-grade gliomas. This article focuses on the potential of these functional and metabolic imaging techniques to refine our clinical target volumes.",

author = "Tsien, {Christina I.} and Yue Cao and Lawrence, {Theodore S.}",

year = "2009",

month = jul,

doi = "10.1016/j.semradonc.2009.02.002",

language = "English",

volume = "19",

pages = "155--162",

journal = "Seminars in Radiation Oncology",

issn = "1053-4296",

number = "3",

}

TY - JOUR

T1 - Functional and Metabolic Magnetic Resonance Imaging and Positron Emission Tomography for Tumor Volume Definition in High-Grade Gliomas

AU - Tsien, Christina I.

AU - Cao, Yue

AU - Lawrence, Theodore S.

PY - 2009/7

Y1 - 2009/7

N2 - Although the addition of concurrent and adjuvant temozolomide (TMZ) to standard-dose radiation (60 Gy) improves survival, the pattern of failure continues to be local. Conventional contrast enhanced T1-weighted and T2-weighted magnetic resonance imaging (MRI) used for radiation planning reflect anatomic rather than molecular or functional, properties of the tumor. Functional and metabolic MRI and positron emission tomography are able to detect metabolic and functional abnormalities beyond the tumor volume seen on conventional MRI, assess early response to treatment, and delineate the regions of high risks for failure in high-grade gliomas. This article focuses on the potential of these functional and metabolic imaging techniques to refine our clinical target volumes.

AB - Although the addition of concurrent and adjuvant temozolomide (TMZ) to standard-dose radiation (60 Gy) improves survival, the pattern of failure continues to be local. Conventional contrast enhanced T1-weighted and T2-weighted magnetic resonance imaging (MRI) used for radiation planning reflect anatomic rather than molecular or functional, properties of the tumor. Functional and metabolic MRI and positron emission tomography are able to detect metabolic and functional abnormalities beyond the tumor volume seen on conventional MRI, assess early response to treatment, and delineate the regions of high risks for failure in high-grade gliomas. This article focuses on the potential of these functional and metabolic imaging techniques to refine our clinical target volumes.

UR - http://www.scopus.com/inward/record.url?scp=65649122677&partnerID=8YFLogxK

U2 - 10.1016/j.semradonc.2009.02.002

DO - 10.1016/j.semradonc.2009.02.002

M3 - Review article

C2 - 19464630

AN - SCOPUS:65649122677

SN - 1053-4296

VL - 19

SP - 155

EP - 162

JO - Seminars in Radiation Oncology

JF - Seminars in Radiation Oncology

IS - 3

ER -

Functional and Metabolic Magnetic Resonance Imaging and Positron Emission Tomography for Tumor Volume Definition in High-Grade Gliomas

Abstract

Access to Document

Other files and links

Fingerprint

Cite this